|
1
|
Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.
|
J Dermatol Sci
|
2011
|
1.20
|
|
2
|
Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma.
|
J Am Acad Dermatol
|
2011
|
1.13
|
|
3
|
Levels of the EMT-related protein Snail/Slug are not correlated with p53/p63 in cutaneous squamous cell carcinoma.
|
J Cutan Pathol
|
2013
|
0.81
|
|
4
|
Hematopoietic progenitor kinase 1, mitogen-activated protein/extracellular signal-related protein kinase kinase kinase 1, and phosphomitogen-activated protein kinase kinase 4 are overexpressed in extramammary Paget disease.
|
Am J Dermatopathol
|
2011
|
0.80
|
|
5
|
Cathepsin K expression: a useful marker for the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
|
Histopathology
|
2010
|
0.78
|
|
6
|
Nerve growth factor, brain-derived neurotrophic factor and their high-affinity receptors are overexpressed in extramammary Paget's disease.
|
J Cutan Pathol
|
2010
|
0.78
|
|
7
|
Aberrant expression of tenascin-c and neuronatin in malignant peripheral nerve sheath tumors.
|
Eur J Dermatol
|
2010
|
0.77
|
|
8
|
Aberrant expression of CD10 in ground-glass-like multinucleated giant cells of multicentric reticulohistiocytosis.
|
J Dermatol
|
2010
|
0.76
|
|
9
|
Arginine metabolism in soft tissue sarcoma.
|
J Dermatol Sci
|
2011
|
0.76
|
|
10
|
Overexpression of stromal cathepsin K expression correlates with invasiveness of extramammary Paget's disease.
|
Eur J Dermatol
|
2010
|
0.75
|
|
11
|
Design of tumor-homing and pH-responsive polypeptide-doxorubicin nanoparticles with enhanced anticancer efficacy and reduced side effects.
|
Chem Commun (Camb)
|
2015
|
0.75
|
|
12
|
Gelatinases may play an important role in the progression of extramammary Paget's disease.
|
Eur J Dermatol
|
2010
|
0.75
|
|
13
|
Expression of cathepsin K in neurofibromatosis 1-associated cutaneous malignant peripheral nerve sheath tumors and neurofibromas.
|
J Dermatol Sci
|
2010
|
0.75
|
|
14
|
Lipoxin A(4), a potential anti-inflammatory drug targeting the skin.
|
J Dermatol Sci
|
2011
|
0.75
|